60 kinds of compound preparations are amazing!

On March 3, the Yangtze River 3 generic drug sodium potassium magnesium sulfate oral solution was approved for production and was deemed to be over-evaluated.
This is a compound preparation composed of sodium sulfate, potassium sulfate and magnesium sulfate
.
According to data from Minet.
com, in 2021E, there will be more than 300 varieties of physical pharmacy terminals in Chinese cities (calculated by drug name, excluding Chinese patent medicines, the same below) with sales exceeding 100 million yuan, of which 60 are compound preparations
.
2021E China's urban physical pharmacies chemical drug terminal sales of over 100 million compound preparations Source: Minet.
com China's urban physical pharmacy terminal competition landscape Compound preparations are preparations that are mixed with two or more different types of drugs
.
Compared with single prescription drugs, compound preparations have the advantages of improving drug compliance, improving drug efficacy, reducing adverse reactions, and reducing drug costs
.
More than 1.
5 billion varieties lead the way, and these 3 compound preparations will exceed 100 million yuan for the first time.
In terms of sales, the total sales volume of 60 compound preparations in 2021E Chinese urban physical pharmacy terminals will exceed 20 billion yuan, a year-on-year increase of about 6%, of which calcium gluconate.
Zinc oral solution led the way with sales of over 1.
5 billion yuan
.
Calcium and zinc gluconate oral solution is an OTC B product.
In recent years, it has maintained a double-digit sales growth rate in Chinese urban physical pharmacy terminals, and has become the best-selling mineral supplement in 2018
.
Aonuo Pharmaceutical has long dominated the market, and will replace Wyeth's calcium carbonate D3 tablets as the first brand of mineral supplements in 2020, with sales expected to exceed 1 billion yuan in 2021
.
In recent years, the sales of calcium and zinc gluconate oral solution in China's urban physical pharmacies (unit: ten thousand yuan) Source: Minet.
com China's urban physical pharmacy terminal competition pattern Pediatric paracetamol Huang Namin Granules and Vitamin AD Drops once again sprinted the 1 billion mark
.
Pediatric Paracetamol Huang Namin Granules is an OTC Class A product.
It is a common cold medicine for children.
The main ingredients include acetaminophen, chlorpheniramine maleate and artificial bezoar.
Its sales exceeded 10 in 2017 for the first time.
100 million yuan, it will decline in 2020 due to the impact of the epidemic, and it is expected to recover in 2021
.
At present, the market of this product is dominated by China Resources Sanjiu, and its market share has increased from 1.
65% in 2017 to 33.
27% in 2020
.
The sales of compound urine retinoid eye drops, sitagliptin and metformin tablets (II), and icogen bacteriostat tablets will exceed 100 million yuan for the first time
.
Sitagliptin Metformin Tablets (II) is a compound hypoglycemic drug composed of sitagliptin phosphate and metformin hydrochloride
.
At present, generic drugs from companies such as Sunshine Pharmaceuticals and Tonghua Dongbao have been approved for listing
.
In recent years, the sales of sitagliptin and metformin tablets (II) in Chinese urban physical pharmacies (unit: ten thousand yuan) Source: Minet.
com China's urban physical pharmacy terminal competition From the perspective of treatment categories, 60 compound preparations cover 9 treatment categories , focusing on the therapeutic fields of digestive system and metabolic drugs (25), respiratory system drugs (11), cardiovascular system drugs (6), it can be seen that compound preparations are widely used in the treatment of chronic diseases
.
The distribution of 60 types of compound preparations in the treatment of major categories 17 types of compound preparations have a bright growth rate, this exclusive variety has soared by more than 100% 2021E China's urban physical pharmacies have terminal sales of over 100 million and a growth rate of more than 10% of compound preparations Source: Minet China City The competition pattern of physical pharmacy terminals From the perspective of sales growth, the sales growth rate of 17 compound preparations in physical pharmacy terminals in urban China in 2021E exceeds 10%, among which Acoen Bacterial Tablets, Compound Calcium Gluconate Oral Solution, and Calcium Carbonate D3 Chewable Tablets , Ambroterol oral solution more than 40%
.
Icogen Bacterial Tablets is an anti-HIV-1 infection compound preparation developed by Gilead.
The main ingredients include elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide
.
The product was approved to enter the domestic market in August 2018, and was included in the National Medical Insurance Category B Catalog through negotiation in 2019.
At present, there are no companies deploying generic drugs
.
In recent years, the expansion of the domestic market of Acoen Bacteriostat is obvious.
It is expected that the sales of physical pharmacy terminals in Chinese cities will exceed 100 million yuan for the first time in 2021, a year-on-year increase of about 186%.

.
In recent years, the sales of Icogen Bacterial Tablets in China's urban physical pharmacies (unit: ten thousand yuan) Source: Minet.
com China's urban physical pharmacy terminal competition pattern Compound calcium gluconate oral solution is an OTC B product, and Harbin Pharmaceutical Sanjing Pharmaceutical's The product was approved for the market in February 2019 and was deemed to have been reviewed.
After that, the volume was rapidly increased, and in 2020, it has grabbed more than 90% of the market share
.
In recent years, the sales of compound calcium gluconate oral solution in Chinese urban physical pharmacies (unit: 10,000 yuan) Source: Minet China's urban physical pharmacy terminal competition pattern exceeds 1 billion star varieties, Chia Tai Tianqing, Kelun, Beite.
.
.
.
.
.
grab the first imitation of 60 compound preparations, sacubitril-valsartan sodium tablets, salmeterol and ficasone inhalation powder spray, dopaszil tablets, icogen acetaminophen, budesonide No first imitation (including the first imitation of dosage form) has been approved for Motero inhalation powder spray (II) and other varieties
.
Some of the over 100 million compound preparations that have not yet been approved for generic drugs Source: Minet database Sacubitril Valsartan is a new type of drug developed by Novartis for the treatment of heart failure.
) and valsartan (angiotensin receptor antagonist), with global sales of $3.
548 billion in 2021
.
The original research product was approved for import in August 2017.
In the first half of 2021, the terminal sales in China's urban public hospitals, county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) exceeded 700 million yuan.
In 2021, the sales of physical pharmacy terminals in Chinese cities will exceed 300 million yuan
.
At present, 11 domestic companies, including Chia Tai Tianqing, Beite, Kelun, Qilu, etc.
, have submitted the product listing application under the new classification, and the competition for the first imitation is fierce
.
Salmeterol-ticasone is a combination of salmeterol and fluticasone propionate for the routine treatment of reversible obstructive airway disease.
It reached a peak of £5.
274 billion in global sales in 2013, and has since declined
.
According to the data from Minet.
com, the sales of GlaxoSmithKline's salmeterol and ficasone inhalation powder in China's public medical institutions have exceeded 1 billion yuan in recent years.

.
At present, 10 domestic companies, including Chia Tai Tianqing, Hengrui, Si Trump Ruite, and Joincare, have submitted the product listing/clinical application under the new classification
.
Budesonide formoterol is a compound preparation composed of budesonide and formoterol fumarate, which is used to treat asthma, chronic obstructive pulmonary disease, etc.
, and reached a global sales peak of 3.
801 billion US dollars in 2014, and has since increased.
fall back
.
In the domestic market, the sales of AstraZeneca's budesonide formoterol inhalation powder (II) will exceed 2 billion yuan in Chinese public medical institutions in 2020
.
Source: Minet database Note: Minet China's urban physical pharmacy terminal competition pattern database is an enlarged version of urban physical pharmacies covering 297 cities and above cities across the country (excluding county and rural physical pharmacies), and continuously monitoring all categories of urban physical pharmacies database
.
The above sales are calculated based on the average retail price of the product in the terminal
.
The statistics are as of March 2.
If there are any omissions, please correct me!